Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high‐risk upper tract urothelial carcinoma: a multicentre retrospective study-Reference-Cited by-同舟云学术

Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high‐risk upper tract urothelial carcinoma: a multicentre retrospective study

Published:2021-02-15 Issue:4 Volume:128 Page:468-476
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Hamaya Tomoko¹,Hatakeyama Shingo¹^ORCID,Tanaka Toshikazu²,Kubota Yuka¹,Togashi Kyo¹,Hosogoe Shogo¹,Fujita Naoki¹,Kusaka Ayumu¹,Tokui Noriko³,Okamoto Teppei¹,Yamamoto Hayato¹,Yoneyama Tohru⁴,Yoneyama Takahiro⁵,Hashimoto Yasuhiro¹,Ohyama Chikara¹⁵

Affiliation:

1. Department of Urology Hirosaki University Graduate School of Medicine HirosakiJapan

2. Department of Urology Aomori Prefectural Central Hospital AomoriJapan

3. Department of Urology Odate Municipal General Hospital OdateJapan

4. Department of Glycotechnology Hirosaki University Graduate School of Medicine HirosakiJapan

5. Department of Advanced Transplant and Regenerative Medicine Hirosaki University Graduate School of Medicine Hirosaki Japan

Funder

Japan Society for the Promotion of Science London

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bju.15346

Reference30 articles.

1. European Association of urology guidelines on upper urinary tract urothelial carcinoma: 2020 update;Roupret M;Eur Urol,2021

2. Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration;Margulis V;Cancer,2009

3. Significance of the timing of ureteral ligation on prognosis during radical nephroureterectomy for upper urinary tract urothelial cancer;Inokuchi J;Int J Urol,2020

4. Comparison of perioperative outcomes between open and minimally invasive nephroureterectomy: a population‐based analysis;Nazzani S;Int J Urol,2019

5. Recent advances in upper tract urothelial carcinomas: from bench to clinics;Shao IH;Int J Urol,2019

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Benefits of Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma Require at Least Three Cycles;Yonago Acta Medica;2024

2. A metachronous bilateral upper urinary tract urothelial carcinoma achieved partial remission by multiple treatment modalities: A case report and literature review;2023-11-14

3. Design and rationale of a single-arm phase II study of neoadjuvant Durvalumab and Gemcitabine associated with Cisplatin or Carboplatin for upper urinary tract urothelial cancer: the iNDUCT trial (NCT04617756);World Journal of Urology;2023-09-12

4. The benefits of adjuvant chemotherapy for upper tract urothelial carcinoma require at least three cycles;2023-06-29

5. Impact of nephroureterectomy on postoperative renal function in upper tract urothelial carcinoma: A multicenter retrospective study;International Journal of Urology;2023-05-02